Frequency of discussing HIV prevention and care topics with patients with HIV: influence of physician gender, race/ethnicity, and practice characteristics

Gender Medicine
Lytt I GardnerAntiretroviral Treatment and Access Studies (ARTAS) Study Group

Abstract

Because people living with HIV now have greater life expectancy and reduced morbidity, there is a greater need for physicians to discuss HIV transmission risk reduction with these patients. Very limited data are available examining how frequently this discussion is held. We examined the frequency of discussing HIV prevention and HIV care topics, as well as the associations of gender, race/ethnicity, and practice characteristics of physicians caring for persons with HIV. In a 4-city (Miami, Atlanta, Baltimore, Los Angeles) survey, 417 licensed physicians who primarily cared for patients with HIV were mailed a 58-item questionnaire about how frequently they discussed HIV transmission risk reduction, adherence to HIV antiretroviral treatment (ART), adherence to opportunistic infection (OI) prophylaxis, and how to take medicines. Multivariate logistic regression analyses were used to examine the association between physician gender, race/ethnicity, and practice characteristics, and the frequency of discussing these topics. A total of 317 physicians responded to the mailed questionnaire. Less than 40% of the physicians reported always discussing HIV transmission risk reduction with patients. In contrast, 83.9% and 65.0% reported alw...Continue Reading

References

Apr 1, 1995·Medical Care·K D BertakisJ A Robbins
Jan 1, 1997·Journal of General Internal Medicine·N LurieJ S Slater
Jan 22, 1998·Journal of General Internal Medicine·J R Curtis, D L Patrick
Aug 18, 1999·JAMA : the Journal of the American Medical Association·L Cooper-PatrickD E Ford
Jan 27, 2000·JAMA : the Journal of the American Medical Association·C C CarpenterP A Volberding
Feb 15, 2001·The New England Journal of Medicine·D MechanicM Rosenthal
Aug 1, 1996·AIDS Patient Care and STDs·S H KerrR Rinaldi
Sep 4, 2001·AIDS Patient Care and STDs·J BluespruceR S Thompson
Nov 16, 2001·Revista Panamericana De Salud Pública = Pan American Journal of Public Health·UNKNOWN Panel on Clinical Practices for Treatment of HIV infection
Aug 10, 2002·JAMA : the Journal of the American Medical Association·Debra L RoterYutaka Aoki
Jun 10, 2003·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Sanny Y ChenWilli McFarland
Jun 13, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·W A DuffusUNKNOWN Antiretroviral Treatment and Access Studies Study Group
Jul 1, 2004·American Journal of Public Health·Lisa R MetschUNKNOWN Antiretroviral Treatment and Access Study Group
Sep 24, 2004·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Janet J MyersStephen F Morin
Dec 13, 2005·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Jeffrey D FisherGerald H Friedland

❮ Previous
Next ❯

Citations

Jul 26, 2012·AIDS Education and Prevention : Official Publication of the International Society for AIDS Education·Kimberly A KoesterJanet J Myers
Nov 2, 2014·Journal of the International Association of Providers of AIDS Care·Osaro MgbereJonathan Aguilar
Jan 17, 2014·Journal of the International Association of Providers of AIDS Care·Eduardo ValverdeJacek Skarbinski
Oct 27, 2015·Journal of the International Association of Providers of AIDS Care·Linda BeerJacek Skarbinski
Sep 27, 2018·Journal of General Internal Medicine·Rob J FredericksenH M Crane
May 31, 2018·Journal of General Internal Medicine·Rob J FredericksenHeidi M Crane

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Acquired Immune Deficiency Syndromes : JAIDS
Peter J Ruane, Edwin DeJesus
AIDS Education and Prevention : Official Publication of the International Society for AIDS Education
Lourdes IllaMario Sanchez-Martinez
The Journal of the Association of Nurses in AIDS Care : JANAC
Patricia P Gilliam, Diane M Straub
© 2022 Meta ULC. All rights reserved